ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 263,24
0,39%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Palisade Bio Inc (PALI)

  7. Palisade Bio Inc (PALI) Actualités

PALI

Palisade Bio (PALI)

Palisade Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PALI
DateHeureSourceTitreSymboleSociété
13/06/202403h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
11/06/202414h30GlobeNewswire Inc.Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108NASDAQ:PALIPalisade Bio Inc
10/06/202415h15GlobeNewswire Inc.Palisade Bio to Present at the Virtual Investor Pitch ConferenceNASDAQ:PALIPalisade Bio Inc
22/05/202422h50Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PALIPalisade Bio Inc
22/05/202422h48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PALIPalisade Bio Inc
22/05/202422h45Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PALIPalisade Bio Inc
21/05/202414h30GlobeNewswire Inc.Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse ModelsNASDAQ:PALIPalisade Bio Inc
20/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PALIPalisade Bio Inc
17/05/202422h51Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PALIPalisade Bio Inc
16/05/202422h44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
14/05/202414h05GlobeNewswire Inc.Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PALIPalisade Bio Inc
13/05/202422h07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PALIPalisade Bio Inc
10/05/202422h52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PALIPalisade Bio Inc
10/05/202422h37Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PALIPalisade Bio Inc
08/05/202423h06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PALIPalisade Bio Inc
07/05/202414h30GlobeNewswire Inc.Palisade Bio Appoints Margery Fischbein to its Board of DirectorsNASDAQ:PALIPalisade Bio Inc
07/05/202413h30GlobeNewswire Inc.Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesNASDAQ:PALIPalisade Bio Inc
02/05/202414h30GlobeNewswire Inc.Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesNASDAQ:PALIPalisade Bio Inc
01/05/202414h30GlobeNewswire Inc.Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)NASDAQ:PALIPalisade Bio Inc
23/04/202414h30GlobeNewswire Inc.Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine ApproachNASDAQ:PALIPalisade Bio Inc
16/04/202414h30GlobeNewswire Inc.Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ StoolNASDAQ:PALIPalisade Bio Inc
11/04/202415h15GlobeNewswire Inc.Palisade Bio to Participate in the Virtual Investor Lunch Break EventNASDAQ:PALIPalisade Bio Inc
10/04/202414h15GlobeNewswire Inc.Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™NASDAQ:PALIPalisade Bio Inc
03/04/202423h30GlobeNewswire Inc.Palisade Bio Announces 1-for-15 Reverse Stock SplitNASDAQ:PALIPalisade Bio Inc
27/03/202413h00GlobeNewswire Inc.Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate UpdateNASDAQ:PALIPalisade Bio Inc
15/02/202414h35GlobeNewswire Inc.Palisade Bio to Present at Digestive Disease Week (DDW) 2024NASDAQ:PALIPalisade Bio Inc
14/02/202420h54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PALIPalisade Bio Inc
13/02/202414h35GlobeNewswire Inc.Palisade Bio Provides Corporate Update and Reiterates GuidanceNASDAQ:PALIPalisade Bio Inc
08/02/202420h40GlobeNewswire Inc.Correction Notice of Palisade Bio’s Press Release Announcing the Appointment of Clinical Advisory Board MembersNASDAQ:PALIPalisade Bio Inc
08/02/202414h05GlobeNewswire Inc.Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion LeadersNASDAQ:PALIPalisade Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PALI

Dernières Valeurs Consultées

TSXV
SPP
Spot Coffee Canada
ASX
WEHHA
Wea Finance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés